D-0299-2015 Class II Terminated
FDA drug recall D-0299-2015 was initiated by Zydus Pharmaceuticals USA Inc on Nov 26, 2014 and is designated Class II. Reason for recall: Failed Tablet/Capsule Specifications: Recall due to wet and/or leaking capsules. The recall status is terminated (terminated Sep 25, 2017). Affected quantity: 58,920 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 24, 2014
- Initiation Date
- Nov 26, 2014
- Termination Date
- Sep 25, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 58,920 bottles
Product description
Benzonatate Capsules, USP, 200 mg, 100-count bottles, Rx only, Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India; Distributed by: Zydus Pharmaceuticals USA, In, Pennington, NJ USA 08534; NDC 68382-248-01, UPC 3 68382 24801 5.
Reason for recall
Failed Tablet/Capsule Specifications: Recall due to wet and/or leaking capsules.
Distribution pattern
Nationwide and Puerto Rico
Code information
Lot #: MP2137, MP2138, MP2139, Exp 01/16; MP3614, Exp 03/16; MP5611, MP5613, Exp 05/16
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0299-2015
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026